(Q37280340)

English

Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

0 references

author name string

Brad Spellberg

1

1 reference

Europe PubMed Central

19 August 2017

Ashraf S Ibrahim

2

1 reference

Europe PubMed Central

19 August 2017

Lin Lin

3

1 reference

Europe PubMed Central

19 August 2017

Valentina Avanesian

4

1 reference

Europe PubMed Central

19 August 2017

Yue Fu

5

1 reference

Europe PubMed Central

19 August 2017

Peter Lipke

6

1 reference

Europe PubMed Central

19 August 2017

Henry Otoo

7

1 reference

Europe PubMed Central

19 August 2017

Tiffany Ho

8

1 reference

Europe PubMed Central

19 August 2017

John E Edwards

9

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

19 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

19 August 2017

197

1 reference

Europe PubMed Central

19 August 2017

7

1 reference

Europe PubMed Central

19 August 2017

967-971

1 reference

Europe PubMed Central

19 August 2017

Threonine-rich repeats increase fibronectin binding in the Candida albicans adhesin Als5p.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Aluminium compounds for use in vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Parenchymal Organ, and Not Splenic, Immunity Correlates with Host Survival during Disseminated Candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Aluminum salts in vaccines--US perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Innate and adaptive immunity in Candida albicans infections and saprophytism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

6 September 2017

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

28 September 2017

Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

3 September 2018

The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717621

3 September 2018

Mice with disseminated candidiasis die of progressive sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18419471

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37280340&oldid=1402891841"